Tirzepatide Research Peptide – 30mg, 60mg & 90mg

Tirzepatide is a synthetic research peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Researchers study its interaction with these two receptors to investigate metabolic signalling, glucose regulation and energy homeostasis. Unlike compounds that target a single receptor pathway, Tirzepatide activates both GIP and GLP-1 receptors. Consequently, it offers researchers an opportunity to explore how these interconnected pathways influence endocrine activity and metabolic processes. Scientists investigate Tirzepatide in experimental models involving insulin signalling, lipid metabolism, appetite-related pathways and metabolic adaptation. Furthermore, studies examine how dual-receptor activity influences cellular responses and physiological regulatory mechanisms. Current research also explores the relationship between GIP/GLP-1 receptor activation and broader metabolic processes, including energy expenditure, adipose tissue biology and glucose homeostasis. Nova Bio Research supplies Tirzepatide research peptide in 30mg, 60mg and 90mg presentations for laboratory and analytical research. Researchers should review the relevant product specifications and batch-specific analytical documentation before use.

Research Applications

Researchers use Tirzepatide to investigate several areas of metabolic and endocrine science:

• Dual-receptor activity: Examine interactions with GIP and GLP-1 receptors.
• Glucose metabolism: Study signalling pathways involved in glucose regulation.
• Insulin signalling: Explore cellular responses associated with insulin-related pathways.
• Energy homeostasis: Investigate mechanisms that influence metabolic balance.
• Lipid metabolism: Examine processes involved in lipid utilisation and storage.
• Appetite-related signalling: Analyse receptor pathways associated with metabolic feedback.
• Adipose tissue research: Investigate cellular mechanisms and metabolic adaptations.
• Endocrine research: Study interactions between hormone receptors and metabolic networks.

These applications describe areas of scientific investigation rather than established clinical benefits.

Product Information

Product Name: Tirzepatide Research Category: Dual GIP/GLP-1 Receptor Agonist Available Presentations: 30mg, 60mg and 90mg Material Type: Synthetic Research Peptide Intended Application: Laboratory, analytical and in-vitro research Analytical Documentation: Consult the relevant batch-specific Certificate of Analysis (COA), where available, for reported testing results and material specifications.

Storage Information

Proper storage helps researchers maintain material integrity throughout laboratory handling.

• Store unopened material at 2°C to 8°C where this temperature range matches the product’s batch-specific storage instructions.
• Protect the material from direct sunlight, excessive heat and moisture.
• Keep containers securely sealed until laboratory preparation.
• Follow validated laboratory procedures and product-specific stability information after preparation.
• Avoid repeated freeze-thaw cycles unless the relevant stability data supports them.

Always follow the storage conditions specified on the product label and supporting batch documentation.

Research Use Only

Tirzepatide supplied by Nova Bio Research is intended strictly for laboratory, analytical and in-vitro research. Not for human or veterinary use, consumption, diagnosis or therapeutic application. This material is not marketed as a medicine or a treatment. Qualified research personnel should handle it according to appropriate laboratory safety procedures.